or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. -0.09
    GTH B Genetron Holdings Limited 0.00
    WGS B GeneDx Holdings Corp. -1.18
    STOK B Stoke Therapeutics, Inc. 0.59
    INMB C INmune Bio Inc. -0.18
    IDYA C IDEAYA Biosciences, Inc. -0.79
    PRAX C Praxis Precision Medicines, Inc. -1.41
    ORIC D Oric Pharmaceuticals, Inc. 2.56
    GH D Guardant Health, Inc. -1.47
    AVTX D Avalo Therapeutics, Inc. -1.92
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Cancer Cancer Treatment Solid Tumors Biology Checkpoint Inhibitor Disease Evidence Based Medicine Immune System Immunotherapy Medicine Molecular Biology Oncology Proteins Systems Biology Amyloid Amyloidosis Antibodies Antineoplastic Drugs Antitrypsin Deficiency

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 2.93
    MRGR C ProShares Merger ETF 2.53
    MNA D IQ Merger Arbitrage ETF 2.51
    SBIO C ALPS Medical Breakthroughs ETF 1.97
    XHS D SPDR S&P Health Care Services ETF 1.87
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare MRGR to SBIO Compare PTH to SBIO Compare PTH to XHS

        Precision Medicine Stocks Recent News

        Date Stock Title
        May 7 GH Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
        May 7 GH Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
        May 7 FUSN Fusion Pharmaceuticals GAAP EPS of -$0.40
        May 7 IDYA IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
        May 7 FUSN Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates
        May 7 IDYA IDEAYA Biosciences GAAP EPS of -$0.53 misses by $0.01
        May 7 IDYA IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
        May 6 ORIC ORIC Pharmaceuticals GAAP EPS of -$0.37 beats by $0.07
        May 6 ORIC ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
        May 6 STOK Analyst Expectations For Stoke Therapeutics's Future
        May 6 GH Curious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics
        May 6 STOK Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
        May 6 STOK Stoke Therapeutics GAAP EPS of -$0.57, revenue of $4.2M
        May 6 STOK Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
        May 2 FUSN Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 PRAX Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
        May 2 WGS GeneDx Holdings Corp. (NASDAQ:WGS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
        May 1 WGS GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript
        May 1 WGS GeneDx Holdings First Quarter 2024 Earnings: Beats Expectations
        May 1 IDYA IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Biology Biopharmaceutical Biotechnology Cancer Treatment Disease Oncology Solid Tumors Systems Biology Biomarkers Checkpoint Inhibitor Clinical Development Clinical Medicine Drug Discovery Evidence Based Medicine Immunotherapy Molecular Biology Proteins Targeted Therapy
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags